FDA Papers, Volume 10U.S. Food and Drug Administration, 1976 |
Dari dalam buku
Hasil 1-5 dari 97
Halaman 15
... patients not following drug dose in- structions is so high that every patient should be regarded as a potential " non- complier . " Hussar suggested several reasons for this , one of which is that patients often are not told the conse ...
... patients not following drug dose in- structions is so high that every patient should be regarded as a potential " non- complier . " Hussar suggested several reasons for this , one of which is that patients often are not told the conse ...
Halaman 22
... was given methotrexate , a substance known to cause birth defects and which is used in human cancer therapy , though not generally in pregnant patients . natal pigs , SPAL will examine how their bodies break. 22 February 1976 / FDA ...
... was given methotrexate , a substance known to cause birth defects and which is used in human cancer therapy , though not generally in pregnant patients . natal pigs , SPAL will examine how their bodies break. 22 February 1976 / FDA ...
Halaman 24
... patient decides to swallow these tablets in- stead of following directions , the drug won't be absorbed the way it ... patients may be in- structed to take the drug on an empty stomach , to assure that the gastric acid in the stomach ...
... patient decides to swallow these tablets in- stead of following directions , the drug won't be absorbed the way it ... patients may be in- structed to take the drug on an empty stomach , to assure that the gastric acid in the stomach ...
Halaman 26
... Patient Labeling of Drugs Backed by Survey A survey made for the Food and Drug Administration shows that consumers find FDA - required patient informa- tion about birth control pills to be useful . An overwhelm- ing majority of those ...
... Patient Labeling of Drugs Backed by Survey A survey made for the Food and Drug Administration shows that consumers find FDA - required patient informa- tion about birth control pills to be useful . An overwhelm- ing majority of those ...
Halaman 28
... patient information leaflets on the drug . FDA and its Obstetrics and Gynecology Advisory Committee and Anti ... patients in whom the benefits outweigh this risk . Drug Firm Letter ' Irresponsible , ' FDA Says FDA has described ...
... patient information leaflets on the drug . FDA and its Obstetrics and Gynecology Advisory Committee and Anti ... patients in whom the benefits outweigh this risk . Drug Firm Letter ' Irresponsible , ' FDA Says FDA has described ...
Edisi yang lain - Lihat semua
Istilah dan frasa umum
action adulterated Advertising and sale Agency amygdalin animal approved Calif cancer cause Charged chemical claimant claims color additives Commissioner of Food Consent decree authorized contained rodent filth Cosmetic Act cyclamate decree authorized release decree ordered destruction Default decree ordered defendants dieldrin Dist Drug Administration Drug Application effective estrogens FDA CONSUMER FDA's Federal firm flour food additives Food and Drug Government hearing aid held for sale held under insanitary ingredients injunction insanitary conditions insect inspection interstate commerce investigators issue Laboratories Laetrile mammography Manufacturing Practice medical devices ment methadone motion Notices of Judgment packaging packed Panel patients PCB's percent petitioners physicians plaintiff prescription procedures proposed protein recall regulations representing the ability safety salvaging samples seized seizure shipment shipped SPAL studies substances sumer summary judgment tablets tion U.S. District Court U.S. marshal vaccine violation vitamins warehouse women York